| First Author | Mota Vieira M | Year | 2020 |
| Journal | Cell Rep | Volume | 32 |
| Issue | 9 | Pages | 108104 |
| PubMed ID | 32877683 | Mgi Jnum | J:306462 |
| Mgi Id | MGI:6715880 | Doi | 10.1016/j.celrep.2020.108104 |
| Citation | Mota Vieira M, et al. (2020) An Epilepsy-Associated GRIN2A Rare Variant Disrupts CaMKIIalpha Phosphorylation of GluN2A and NMDA Receptor Trafficking. Cell Rep 32(9):108104 |
| abstractText | Rare variants in GRIN genes, which encode NMDAR subunits, are strongly associated with neurodevelopmental disorders. Among these, GRIN2A, which encodes the GluN2A subunit of NMDARs, is widely accepted as an epilepsy-causative gene. Here, we functionally characterize the de novo GluN2A-S1459G mutation identified in an epilepsy patient. We show that S1459 is a CaMKIIalpha phosphorylation site, and that endogenous phosphorylation is regulated during development and in response to synaptic activity in a dark rearing model. GluN2A-S1459 phosphorylation results in preferential binding of NMDARs to SNX27 and a corresponding decrease in PSD-95 binding, which consequently regulates NMDAR trafficking. Furthermore, the epilepsy-associated GluN2A-S1459G variant displays defects in interactions with both SNX27 and PSD-95, resulting in trafficking deficits, reduced spine density, and decreased excitatory synaptic transmission. These data demonstrate a role for CaMKIIalpha phosphorylation of GluN2A in receptor targeting and implicate NMDAR trafficking defects as a link to epilepsy. |
